Symbotic Books $721 Million in Quarterly Revenue From Warehouse Robots
The warehouse automation company has paying customers and a $22.5 billion backlog, but Walmart still accounts for most of its business.
Stocks
Markets, companies and the economy, from New York and Frankfurt to Istanbul and Tokyo.
Page 79 of 89
The warehouse automation company has paying customers and a $22.5 billion backlog, but Walmart still accounts for most of its business.
Stocks
Netskope’s stronger sales outlook and rising AI-security interest won analyst upgrades, while a billing shift weighed on cash flow.
Stocks
The fee-free program adds lifestyle perks as Ally tries to connect savings, spending and investing across its growing digital bank.
Stocks
Both companies are growing with data-center demand, but Vertiv’s faster organic sales growth comes with a more concentrated infrastructure bet.
Stocks
Baron increased its multifamily holdings, citing a better supply outlook and improving fundamentals in markets including San Francisco.
Stocks
A repeat £342,000 medical-device order lifts the contract above £500,000 as the electronics maker pursues defence work and adds inspection equipment.
Stocks
New and acquired products brought in $3.2 billion globally in the second quarter, as Pfizer steers resources toward growth areas.
Stocks
Shares had more than doubled in 2026 as investors looked for evidence that AI identity products can drive durable growth.
Stocks
A 24/7 Wall St. model sees further gains for Buffett’s longtime holding, backed by stronger sales and a higher 2026 earnings forecast.
Stocks
Both steelmakers expect higher third-quarter earnings, but their forecasts fell short of Wall Street estimates after strong runs in their shares.
Stocks
The Danish drugmaker promised new blockbuster medicines and expanded pill capacity, but investors wanted a clearer measure of growth before patents expire.
Stocks
Strong sales and higher guidance fuel the recovery case, but some analysts question how much progress the share price already reflects.
Stocks
Quest Diagnostics remains well ahead of the Nasdaq in 2026, though a new Medicare payment proposal sent shares lower.
Stocks
Nine analysts raised MiniMed price targets after strong quarterly growth, but separation costs and a calendar boost complicate the cash-flow picture.
Stocks
Workday surged 64% in three months, far ahead of software peers, though acquisition speculation and a weak year-to-date return complicate the picture.
Stocks
VOO charges 0.03% annually and spreads exposure across large U.S. companies, but its history cannot predict how Anthropic shares will perform.
Stocks
A steep share-price slide has brought Netflix’s forward earnings multiple down, but slowing sales growth and weaker engagement remain investor concerns.
Stocks
The CNBC host cited Chili’s $10.99 meal deal and sales momentum, while Darden’s Olive Garden remained a key point to watch.
Stocks
Shares hit a 52-week low as growth forecasts and cash reserves compete with rising incentives and a costly lending acquisition.
Stocks
The used-car retailer says the cuts support a leaner workforce as CEO Keith Barr pursues $200 million in expense savings.
Stocks
New controls for AI models and agents arrive as Fastly highlights security growth and rising machine-generated traffic to investors.
Stocks
Record memory sales and long-term customer deals strengthen the case for Micron, but investors face a key test on September 30.
Stocks
DIS is down more than 7% this year, while stronger quarterly profit and a lower valuation give investors reasons to keep watching.
Stocks
A dozen analysts raised Samsara’s targets after strong results, while several kept neutral ratings as forecast growth slows from its latest pace.
Stocks